FDA Begins cGMP Reinspection Of Teligent’s Key Facility
US Firm’s Buena Site Received Warning Letter Late In 2019
• By Akriti Seth
Teligent unsure of when the FDA will provide results of the inspection and reinspection of its Buena, New Jersey manufacturing facility • Source: Alamy
Stay ahead of every shift in generics and biosimilars.
Generics Bulletin brings you the latest updates that matter for the off-patent industry.
